RxDoctor Payments DataLook up a doctor →

Gregory Boyd, DO

Family Medicine · Grandview, MONPI 1821107939

Payments from drug & device makers

$19,712in general payments, 2019–2025

Across 1,165 payments — averaging $16.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$3K
  • AbbVie$2K
  • Novo Nordisk$2K
  • Lilly USA, LLC$1K
  • Pfizer$1K
  • Amarin Pharma, Inc.$1K
  • plus $10K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca92$2,668
AbbVie(2 entities)141$2,193
Novo Nordisk116$1,672
Lilly USA, LLC104$1,349
Pfizer90$1,136
Amarin Pharma, Inc.47$1,124
Amgen48$987
Boehringer Ingelheim68$943
GSK50$735
Takeda Pharmaceuticals U.S.A., Inc.41$625
Abbott31$555
Bayer22$455
Antares Pharma, Inc.32$411
Merck32$382
Johnson & Johnson12$361
Astellas Pharma US Inc16$344
Esperion Therapeutics, Inc.14$332
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC22$317
Novartis9$295
Eisai Inc.17$246
Corium, LLC12$240
Otsuka America Pharmaceutical, Inc.12$206
Kowa Pharmaceuticals America, Inc.15$188
Adlon Therapeutics L.p.13$176
Biohaven Pharmaceutical Holding Company Ltd.7$154
Biohaven Pharmaceuticals, Inc.9$137
Teva Pharmaceuticals USA, Inc.9$132
Daiichi Sankyo Inc.4$94
Bausch Health US, LLC6$84
Boston Scientific2$76
Sumitomo Pharma America, Inc.5$73
Nevro Corp.4$71
Phathom Pharmaceuticals, Inc.4$70
Zyla Life Sciences, Inc.6$67
Clarus Therapeutics Inc.7$65
Lundbeck LLC3$64
Pharming Healthcare, Inc.3$57
Insulet Corporation3$53
Shire North American Group Inc3$50
Mannkind Corporation3$48
Exact Sciences3$42
Sanofi Pasteur Inc.3$41
Axsome Therapeutics, Inc.2$40
Radius Health, Inc.2$35
Xeris Pharmaceuticals, Inc.2$34
Paratek Pharmaceuticals, Inc.2$31
Silk Road Medical, Inc.1$31
Aytu Biopharma, Inc.2$30
Genentech USA, Inc.2$25
Cequr Corporation2$21
Sanofi-aventis U.S. LLC1$21
Neurelis, Inc.1$17
VBI Vaccine (delaware) Inc.1$17
Impel Pharmaceuticals Inc.1$16
E.r. Squibb & Sons, L.L.C.1$14
Collegium Pharmaceutical, Inc.1$14
Almatica Pharma LLC1$13
Circassia Inc.1$12
Ironwood Pharmaceuticals, Inc1$12
Jazz Pharmaceuticals Inc.1$11

How this compares

$19,712 in reported general payments places this provider in the 95th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri →

Medicare billing

Part B allowed, 2024
$112,589
Medicare patients
284
Services billed
3,527

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Grandview

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →